Patients facing a relapse of diffuse large B-cell lymphoma often encounter complex choices about their next steps in treatment. Here, Dr. Krushangi Patel helps outline the key considerations for ...

Living with the most common type of non-Hodgkin’s lymphoma, diffuse large B-cell lymphoma, is about more than treatment cycles and scans. It’s about how you live in the midst of it — equipping ...

“I think the biggest role for the caregiver is: if the person has some worrisome symptom or signs, the caregiver [must] make sure that that person gets it attended to. Either by calling the physician ...

Bridging therapy is a critical short-term strategy used after relapse to keep fast-moving lymphoma under control while patients wait for their personalized CAR T-Cells to be manufactured. Its goal is ...

After a cancer diagnosis, it’s normal to experience a wide range of emotions, such as anxiety, frustration, fatigue, and a sense of loss of control. Treatment for diffuse large B cell lymphoma (DLBCL) ...

CAR T-Cell Therapy is transforming the outlook for people with diffuse large B-cell lymphoma — offering a second chance at remission when standard treatments fail. But, this powerful immune response ...

Dr. Rodrigo C. Leão Edelmuth is a Board Certified Digestive Surgeon at Einstein Hospital Israelita in Sao Paulo, Brazil. Einstein is internationally acclaimed, ranked 22nd best hospital in the world ...

Dr. Jeff Jones, 66, has spent his life preparing others for liftoff—first as a U.S. Navy aviator, then as a NASA flight surgeon. But when prostate cancer grounded him with a diagnosis of his own, he ...